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Abstract
Transcription Activator-Like (TAL) effectors are DNA-binding proteins secreted by phytopathogenic bacteria that interfere
with native cellular functions by binding to plant DNA promoters. The key element of their architecture is a domain of
tandem-repeats with almost identical sequences. Most of the polymorphism is located at two consecutive amino acids
termed Repeat Variable Diresidue (RVD). The discovery of a direct link between the RVD composition and the targeted
nucleotide allowed the design of TAL-derived DNA-binding tools with programmable specificities that revolutionized the
field of genome engineering. Despite structural data, the molecular origins of this specificity as well as the recognition
mechanism have remained unclear. Molecular simulations of the recent crystal structures suggest that most of the protein-
DNA binding energy originates from non-specific interactions between the DNA backbone and non-variable residues, while
RVDs contributions are negligible. Based on dynamical and energetic considerations we postulate that, while the first RVD
residue promotes helix breaks – allowing folding of TAL as a DNA-wrapping super-helix – the second provides specificity
through a negative discrimination of matches. Furthermore, we propose a simple pharmacophore-like model for the
rationalization of RVD-DNA interactions and the interpretation of experimental findings concerning shared affinities and
binding efficiencies. The explanatory paradigm presented herein provides a better comprehension of this elegant
architecture and we hope will allow for improved designs of TAL-derived biotechnological tools.
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Introduction
TAL (Transcription Activator-Like) effectors are proteins
secreted by phytopathogenic Gram-negative bacteria from the
Xanthomonas genus [1], responsible for the infection of more than
200 different plant families, including many crops [2]. TAL
effectors are injected directly into the host plant cells via Type III
Secretion System (T3SS) and, after localization to the nucleus,
specifically bind to DNA sequences, thus interfering with native
cellular functions and supporting infection [1]. Endogenous TAL
proteins are composed of an N-terminal translocation signal
necessary for T3SS injection, a C-terminal nuclear localization
signal (NLS) domain and an acidic activation domain (AD), both
important eukaryotic motifs (Figure 1A) [2,3]. The central domain
is composed of a variable number of tandem- repeats, ranging
from 1.5 to 33.5, with 17.5 being the most abundant [2]. The
number of repeats correlates with the number of base pairs in the
targeted sequence and each repeat is composed of an almost
invariable stretch of 34 amino acids [2]. Polymorphism among
repeats occurs predominantly at positions 4, 12, 13 and 32
(internal numbering), with positions 12 and 13 being by far the
most variable, and accordingly termed Repeat Variable Diresidue
(RVD) [2,4].
TAL systems recently gained wider attention after a direct
relationship between the RVD type and the targeted DNA base
was established by both experimental [5] and bioinformatics
methods [4]. The DNA specificity of RVDs is univocally
determined for only some amino acid combinations, while in
many cases affinity for multiple nucleobases is observed [4].
Position 12 was found to be either H or N, and position 13 being
one of D, G, I, N, S, A, K or missing altogether (*). The
combination of these amino acids accounts for about 95% of all
known RVDs (Figure 1B) [4]. The discovery of this code opened
the way to unforeseen applications, far beyond the scope of plant
cell manipulation. TAL-based tools established a new landmark in
site-specific genome regulation and modifications. Fusion of TAL
with activator or repressor domains has provided functional
transcription factors with desired sequence specificities [527] and
careful design has allowed orthogonal site-targeting [8]. Fusion
with nucleases has yielded tools for site-specific double-strand
break generation, for either gene knockout or user-defined cassette
insertion [9212]. TAL nucleases (TALENs) have been shown to
work in a wide range of organisms, from yeast to mammalian cells
[7,12216]. If geneticists had ever dreamed of a modular and
predictable DNA-targeting tool, it probably would have resembled
TAL.
The understanding of the structural features of TAL effectors in
general, and their relationships to DNA-binding in particular, are
essential steps towards effective protein engineering for tailored
biotechnological applications. Following the first structural NMR
data of a single TAL repeat [17], both DNA-bound and free forms
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of TAL proteins have been crystallized. Mak et al. obtained the
structure of PthXo1, a naturally-occurring 23.5 repeats TAL
bound to its corresponding DNA target, at 3 A˚ resolution [18]
(PDB code: 3UGM), while Deng et al. solved the structure of a
designed 11.5 repeats TAL system in both bound and unbound
states with resolutions of 1.85 A˚ and 2.5 A˚ respectively [19] (PDB
codes: 3V6T, 3V6P). All structures showed the same overall
architecture, with TAL forming a right-handed, highly symmet-
rical super-helix wrapped around a regular B-DNA double-strand
(Figure 2). Each repeat is composed of two anti-parallel helices, a1
and a2, the latter being roughly twice as long as the former and
possessing a kink at the position of residue P27 (Figure 1A/C). The
RVD, located on the loop linking a1 to a2, interacts with the
major groove of the DNA sense strand. Residues K16 and Q17,
close to the RVD loop, also contribute to DNA binding through
non-specific polar and charged interactions with the DNA
backbone. Although each RVD consists of two amino acids, only
the residue at position 13 seems to directly interact with DNA in
the crystal structures. It has been suggested that position 12
influences the orientation of the side-chain of residues at position
13 through non-direct interactions such as water-bridges and
RVD loop stabilisation [19]. The crystallographic structures
provided a molecular perspective on the process of DNA
recognition mediated by RVDs, highlighting in particular the
interaction of D13 with the amino group of cytosine, the van der
Waals contact of G13 with the methyl group of thymine, the
electrostatic interaction of N13 with nitrogen 7 of purine bases and
the van der Waals interactions of I13 with either adenine or
cytosine [18,19]. The molecular basis of the different interactions
has been reviewed on the basis of the crystallographic structures
[20,21].
Although those structures have provided a much clearer
understanding of DNA recognition by TALs, some aspects of this
unique mechanism still remain elusive. In particular, the source of
high specificity in RVD-DNA base recognition – despite limited
interactions – and the grounds for both RVD compositions and
occurrences are still unclear. Moreover, the structural roles of the
other residues and their importance to protein function have not
been addressed yet. Furthermore, although the RVD-to-DNA
code has been shown to work well in most cases, some
combinations have proven sub- or non-functional, raising the
issue of context dependence [12,15,22]. Finally, the role of DNA
methylation on TAL-DNA binding [23] should be extended to
other RVDs compatible with methylated DNA. Addressing these
points will prove essential for achieving full protein-engineering
capabilities and effectively design new TAL systems with improved
DNA-binding abilities and specificities. In this report, we sought to
address these questions by using molecular dynamics (MD)
simulations to complement the picture obtained from crystallo-
graphic structures with dynamical and energetic information.
Materials and Methods
Molecular dynamics simulations
The available crystal structures of both free (PDB code: 3V6P)
[19] and DNA-bound (PDB codes: 3UGM, 3V6T) [18,19] TAL
effectors were used to build model systems in the framework of
classical molecular mechanics [24]. Molecular dynamics simula-
tions using NAMD 2.8 [25] with the AMBER ff99brsc force field
[26], an explicit solvent model (TIP3P [27]) and periodic
boundary conditions were performed on the constructed systems
to complement the information obtained from the X-ray structures
Figure 1. TAL topology and RVD-to-DNA code. (A) Sequence of a
TAL protein: type III secretion system tag (T3SS-tag, violet), tandem-
repeat domain (blue), nuclear localization signal (NLS, yellow) and acidic
transcriptional activation domain (AD, green). The amino acid sequence
of a single repeat is shown, highlighting the RVD region (X12 and X13).
The secondary structure is reported underneath; the kink induced by
P27 is represented as a break in the a2 rod. (B) Natural occurrence of
the known RVDs is reported together with the targeted DNA base to
highlight RVD selectivity [4]. While some RVDs target only a single base
(e.g. HD and ND), others have shared affinities (e.g. NN and N*). (C)
Representative structure of one repeat as extracted from the 3V6T
structure; relevant molecular information is highlighted.
doi:10.1371/journal.pone.0080261.g001
Figure 2. TAL repeats architecture. (A) Top view of bound TAL
along the DNA axis showing the N-terminus (structure from 3UGM). (B)
Side view of bound TAL displayed from the N-terminus (bottom) to the
C-terminus (top) (structure from 3UGM). (C) TAL without DNA and the
RVDs explicitly depicted (laying on the inner-side of the super-helix).
The orange line represents the DNA axis. The protein is orientated from
N-terminus (bottom) to C-terminus (top). A larger pitch compared to
the bound structure is clearly observable (structure from 3V6P). Protein:
grey; DNA: orange.
doi:10.1371/journal.pone.0080261.g002
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[28] (Table 1). First, geometry optimisations with 1000 steps of
energy minimization using a conjugate gradient were performed in
order to relax the systems. Dynamics started by an equilibration in
the NVT ensemble at 100 K, followed by a gentle rise of the
temperature to 300 K in 300 ps and a further NVT (300 K)
equilibration phase. All those steps were performed with a
harmonic constrain applied to the heavy atoms (i.e. not H) of the
protein and DNA. Productions were run in the NPT ensemble (1
atm, 300 K) with all atoms free. Langevin dynamics was used to
enforce ensemble parameters. A 12 A˚ cutoff distance was defined
for short-range interactions, while the Particle Mesh Ewald
summation method was used to compute long-range interactions.
The RATTLE algorithm was used to treat covalent bonds
involving hydrogen atoms in order to allow an integration step
of 2 fs. Ions (Mg2+ and Cl2) were added to the systems to
neutralize charges and obtain a final magnesium concentration
mimicking physiological conditions (,50 mM). The structural
ensembles generated by MD simulations were used to establish
statistics on the conformational states accessible to the systems.
This information was used to highlight the structural importance
of certain residues in the protein architecture and for the DNA
recognition mechanism. Full details about system set-ups and MD
simulation protocols are reported in Methods S1.
Binding energy calculations
To further investigate TAL specificity, energy decompositions of
pairwise interactions were performed using MM/GBSA (Molec-
ular Mechanics/Generalized Born Surface Area) and MM/PBSA
(Molecular Mechanics/Poisson Boltzmann Surface Area) implicit
solvent calculations in order to identify the hot spots at the protein-
DNA interface and the stabilizing interactions within TAL
[29231]. All calculations were performed with the parallelized
version of MM/PB(GB)SA implemented in the Amber 11 suite of
program [32] using the standard single-trajectory approach.
Entropy contributions were not taken into account. Each MM/
PB(GB)SA calculation was performed on 500 snapshots evenly
taken from the last 30 ns of the corresponding equilibrated
simulations (one snapshot every 6 ps of MD simulation).
Furthermore, a non-standard procedure involving MM/GBSA
and MM/PBSA calculations was performed in order to qualita-
tively estimate the dependence of binding energy on the number of
TAL repeats wrapping the DNA double-strand (cf. Methods S1
and Figure S12).
Quantum mechanical calculations
Quantum mechanical calculations were performed to obtain the
molecular electrostatic potential (MEP) of DNA bases. The
Gaussian 09 suite of program [33] was used to perform geometry
optimisation and MEP calculations of nucleobases at the B3LYP/
6-31+G*//B3LYP/6-31+G* level. Methyl caps were added on the
N9 of purine bases and N1 of pyrimidine bases.
Results and Discussion
DNA templates TAL architecture and rigidifies the RVD
motif
All simulated TAL-DNA systems showed comparable root
mean square deviations and positional fluctuations; between 4.0
and 4.8 A˚ for the large systems, and between 1.9 and 2.5 A˚ for the
small systems. Differences among system categories (TAL[22.5] or
TAL[11.5]) are not statistically significant (cf. Figures S1-S3 a, b
and c, e, f). All systems are stable with conservation of secondary
structure within the simulated time-scales (Figure S4). For the
DNA-bound systems, larger structural fluctuations were observed
at the distorted termini (Figure S3). Within the tandem-repeat
section, the largest fluctuations were found in the peripheral
regions of each, while the innermost residues in contact with DNA
(including the RVDs) showed a remarkable reduced mobility
(Figure 3A and Figure S5). Interestingly, different structural
fluctuations were observed for the sense (i.e. recognised by TAL)
and anti-sense strands of DNA (see Figure S1 a, b, c, e, f). Those
data are in accordance with the B-factors of the crystallographic
structures.
In the absence of DNA, TAL proteins are more flexible (Figures
S1-S3 d, g) and the RVD loops fluctuate as much as the outer
region (Figure 3A and S5 d, g) – 2.1 +/2 0.5 A˚ when unbound vs
0.6 +/2 0.2 A˚ when bound; values are for the RVD loops of the
small system – showing an overall stabilizing effect of the DNA
double helix on TAL architecture. Moreover, when DNA is
removed from the DNA-bound crystal structure 3V6T prior to
simulation (TAL[11.5]/P1-apo), the protein rapidly stretches and
the pitch approaches that of the unbound TAL 3V6P (Figure 2C).
This dependence of the pitch value on the presence of DNA is
consistent with the results of Murakami et al. [17], reporting that
adjunction of dsDNA to TAL reduced its hydrodynamic radius.
Taken together these results indicate that DNA acts: i) globally, as
template in the structural rearrangement of TAL systems from a
Table 1. Simulation details for each system.
PDB Selected System
RVD His
Protonation
Number of
Atoms Box Size [A˚3]
Simulation
Length [ns]
TAL[22.5]/P1 3UGM Protein: 192 to 1048 (chain A); DNA: 26 to 29
(chain B) and 1 to 36 (chain C)
Nd 158675 10661516107 53
TAL[22.5]/P2 3UGM Protein: 192 to 1048 (chain A); DNA: 26 to 29
(chain B) and 1 to 36 (chain C)
Ne 158675 10661516107 61
TAL[11.5]/P1 3V6T Protein: 231 to 721 (chain A); DNA: 22 to 14
(chain I) and 214 to 2 (chain J)
Nd 107599 10161026112 127
TAL[11.5]/P3 3V6T Protein: 231 to 721 (chain A); DNA: 22 to 14
(chain I) and 214 to 2 (chain J)
Nd + Ne (charged) 107618 10161026112 57
TAL[11.5]/P4 3V6T Protein: 231 to 721 (chain A); DNA: 22 to 14
(chain I) and 214 to 2 (chain J)
Nd + Ne (charged
and ring flipped)
107618 10161026112 42
TAL[11.5]/P1-apo 3V6T Protein: 231 to 721 (chain A); DNA: no DNA Nd 107635 10161026112 51
TAL[10]/P1-apo 3V6P Protein: 303 to 675 (chain A); DNA: no DNA Nd 95742 108696699 56
doi:10.1371/journal.pone.0080261.t001
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stretched to a packed structure and ii) locally, to stabilize and
reduce the mobility of the RVD loops.
TAL repeats are packed through stabilizing interactions
The analysis of the interaction energetics extracted from MD
simulations revealed that most of the intra-protein stabilization is
due to non-specific backbone-backbone interactions within a-
helices (Figures S6-S7). This property is consistent with the large
helical content of the protein and the requirements for secretion
through the T3SS injectisome. According to recent studies on
T3SS [34], protein effectors partially unfold to cross the narrow
injectisome needle. Thus, TAL systems, composed by loosely
connected a-helices, can cross the needle without significant loss of
secondary structure. Specific side-chain interactions occur mostly
at the transition between coil-regions and a-helices and between
consecutive repeats (Figure S8). The interactions between the
outer-coil and a1 (including T2 to A4/Q5 and Q5 to L1/T2) are
energetically significant and stable over dynamics. Interaction of
the hydroxyl group of S11 with the backbone carbonyl of V7 and
interaction of an N-H from the X12 side-chain (first RVD residue;
either asparagine or histidine) with the I9 backbone carbonyl
represent significant energetics at the structural transition between
a1 and the RVD loop. Surprisingly, the interaction of X12 with
the backbone carbonyl of A8 reported in the crystal structure [19]
was less significant from an energetic point of view (Figure S8).
This interaction pattern suggests that the mentioned residues
promote a structural transition from coil to helix and vice versa; an
essential feature to attain the DNA-wrapping super-helix archi-
tecture characteristic of TAL proteins. Interactions of repeat i with
its neighbours i-1 and i+1 are mainly constituted by K16(i)-Q17(i-
1) and E20(i)-R24(i-1), forming a stable H-bond network linking
together the TAL repeats in a regular and stable structure (Figures
S8). Much less important are the interaction of H33(i) with
Q23(i+1)/L26(i+1)/P27(i+1), all located at the kink generated by
P27 (Figure S8). The presence of this conserved motif among
repeats could suggest a pH-responsive mechanism for protein
packing during secretion, with the strength of both intra- and
inter-repeat interactions being modulated by the protonation state
of histidine. However, further experimental evidences are required
to address this proposition.
RVDs marginally contribute to TAL-DNA interaction
energetics
Detailed information about TAL-DNA interactions at the
single-residue level can be extracted from the decomposition of
pairwise interaction energies as calculated at the molecular
mechanics level [24] and averaged over equilibrated MD
trajectories using an implicit solvent model (Figure 3B/C and
Figures S9-S11). This approach has been successfully applied to
Figure 3. Structural and energetic features of TAL-DNA interaction. (A) Mean residue fluctuation (RMSD) computed for the DNA-bound and
apo states of the 11.5-repeats TAL system (TAL[11.5]/P1 and TAL[11.5]/P1-apo); averages are performed over all the repeats; bars represent standard
deviations. The same trend is observed for all simulated systems (cf. Figure S5). (B) Contribution to the total DNA-binding energy from different
sections of TAL subdivided by type and calculated on the DNA-bound 22.5-repeat TAL system (TAL[22.5]/P1) using MM/GBSA (Number of residues
contributing to each type: G13= 6, N13 = 2, I13 = 7, D13= 5, G14/K16/Q17= 20, others = 600, N-terminus = 97). Repeats containing a deletion at
position X13 have been excluded from the statistics. (C) Per repeat mean energy contribution to the total DNA-binding energy; averages are
performed over all the repeats of the DNA-bound 22.5-repeat TAL system (TAL[22.5]/P1). Repeats containing a deletion at X13 position have been
excluded from the statistics. The complete binding energy profile is reported in Figure S9.
doi:10.1371/journal.pone.0080261.g003
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investigate the energetics of protein-protein as well as protein-
DNA interactions [35239].
Strikingly, non-specific interactions between DNA backbone of
the sense strand and residues G14, Q17 and K16 account for most
of the overall binding energy of TAL proteins to DNA (Figure 3B/
C). The N-terminal region also contributes significantly to the
binding (Figure 3B and Figures S9-S11), consistent with the
experimental finding that the N-terminus serves as a nucleation
point for DNA wrapping after non-specific interactions with an
upstream sequence [5,40]. Unexpectedly, when considering the
high specificities of TAL proteins for their targets, both RVD
residues contribute only to a small fraction of the total DNA
binding energy. The first position in each RVD (X12, either H or
N) does not form any direct interaction with DNA, neither in the
major-groove, nor with the backbone of the lagging strand (Figure
3C and Figures S9-S10), but instead forms a stable interaction
with the carbonyl group of I9 (Figure S8). The presence of
histidine residues at the first position of certain RVDs prompted us
to investigate the effect of its different protonation states. However,
no statistically significant differences on binding energetics and
dynamical behaviours were observed (see Figures S1-S5 a, b and
c, e, f and S11). The second position of each RVD (X13) accounts
for a small, although significant, fraction of the remaining DNA-
binding energy (Figure 3B/C). Not only does it interact with its
cognate nucleobase, but it also makes a substantial interaction with
the preceding DNA base (Figure 3C). As a matter of fact, on
average, interaction between each ith RVD and the i-1 nucleobase
is stronger than the interaction with the ith base. This effect can be
attributed to NG RVDs, which constitute the largest fraction of all
the RVDs found in the 23.5-repeat structure (Figure S9). Results
from electrophoretic mobility shift assays showed that NG was the
RVD with the highest DNA-binding properties [41], thus
correlating with our energetic data. Although unexpected, this
observation can be explained by considering the stair-like
arrangement of DNA bases. The same effect has been observed
for another DNA-binding protein, where correlation has been
made between binding energy and the molecular surface of
nucleobases displayed to protein side-chains [42]. This phenom-
enon provides a rationale for context dependence of TAL DNA-
binding. Indeed, depending on the combination of RVD and i-1
DNA base, this extra interaction could either be favoured or
disfavoured, in turn affecting the overall binding of TAL to DNA.
The origin of TAL-DNA specificity
TAL systems have evolved to bind DNA sequences with high
specificity. Selectivity is ensured by a central domain composed of
a variable number of repeats, each responsible for recognizing a
single base. The capability of TAL to bind the target sequence can
be often impaired by disruption of only one RVD-base interaction
[15]. Strikingly, only a small subset of the 20 natural amino acids is
present in the naturally occurring RVDs, with about 95% of all
known RVDs obtained from the combination of H, N, I, D, S, and
G only. Both X-ray structures and our dynamical simulations
indicate that there is neither interaction between the two RVD
residues nor correlated motion. Thus, the amino acid populations
of position 12 and 13 can be treated separately and their effect on
DNA binding and base selectivity deconvoluted.
The first RVD position (X12) is almost always either H or N,
the side-chain of either of them forming a stable interaction with
the backbone carbonyl of I9; this promotes the helix break
between a1 and a2 and allows the formation of the RVD loop in
between. The low intrinsic a-helix propensities of N and H
[43245] also argue for X12 as a helix-breaker. This hypothesis is
further supported by the strong interaction energetics of S11 with
the backbone carbonyl of V7, further contributing to the
formation of the RVD loop. This suggests a purely structural role
for X12, unrelated with the DNA recognition process. The
grounds for two different side-chains to perform a seemingly
identical task remains elusive but the recurrent H12-D13 RVD
motif could imply either a dependence to pH or a way to stabilize
the negative charge of the aspartate (D13) in the strong electric
field present close to the phosphodiester DNA backbone.
However, no relevant differences in either dynamical features or
DNA-binding energetics were observed between systems featuring
different protonation states of the histidine side-chain (see Figures
S1-S5 a, b and c, e, f and S11).
All the residues observed at the second RVD position (X13)
share with H and N (at X12) a very low intrinsic a-helix propensity
[43245], which is consistent with the observed coil arrangement.
As evident from X-ray structures, the side-chain of X13 is closer to
the DNA base than X12, thus making X13 the key player in
molecular recognition and base discrimination. MD simulations
revealed a very low structural fluctuation of the RVD loop (Figure
3A) and energetic analysis showed TAL-DNA binding (Figure 3B/
C) dominated by an oxyanion clip constituted by G14, K16 and Q17
(GGKQ in Figure 4A). These data taken together suggest a very
important role for the oxyanion clip in anchoring and spatially
constraining the RVD loop, effectively giving very little leeway to
the side-chain of X13. Additionally, bulky residues are not
compatible at the X13 position because their side-chain would
difficultly be accommodated in the narrow gap at TAL-DNA
interface.
A structural model to interpret TAL specificity
The geometrical constraints on the backbone of the RVD loop
and the restrictions on both size and conformational freedom of
the X13 side-chain are the key elements to understand nucleobase
discrimination and amino acid occurrences in RVDs. A simple
unified pharmacophore-like model for both purines and pyrimi-
dines has been constructed to highlight the nature and extent of
the dynamical interactions between the nucleobase and the X13
side-chain over the course of our simulations (Figures 4A). Since
only a small portion of the nucleobase is accessible by X13 (loci a,
b, c; corresponding to substituents on C4, C5, C6 for pyrimidines,
and C6, N7, C8 for purines), full discrimination between different
bases is, in some cases, imperfect and molecular recognition
ambiguous, consistent with experimental findings about the shared
(none-univocal) specificities of some RVDs (e.g. NN, N*, NS)
[4,5,22].
The pharmacophore-like model, together with the cartoon of
Figure 4A, allows to rationalize the RVD-to-DNA code. As an
example, N13 (e.g. in the NN RVD) clearly favours purine bases
over pyrimidine bases owing to the lack of steric clashes with
groups on a and b (missing in purines, Figures 4) and to the
possibility to form a H-bond with the pyridine-like nitrogen N7 (c).
Nevertheless, recognition based on H-bonding fails to discriminate
between adenine and guanine due the impossibility to access –
during dynamics – all the loci required for a complete molecular
differentiation. This explains the observed selectivity of N13 for
both purine bases. NN-containing TALs were recently reported to
display greater affinity when targeting guanosine over adenine
[22,41], which is easily understandable by comparing the
molecular electrostatic maps of guanine and adenine. Both possess
a pyridine-like nitrogen with a lone-pair, which has been
postulated to be the interaction centre recognized by asparagine.
However, the nearby carbonyl moiety of guanine make the N7
position electrostatically more negative, increasing the strength of
interaction with H-bond donors, which is reflected in the
TAL Effectors Specificity
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respective binding activities. On the contrary, I13 (in NI RVD)
perfectly targets adenine on the basis of charge distribution, dipole
moment and steric discrimination. Indeed, the larger dipole
moment of guanine [46] provides a poorer match for the
hydrophobic side-chain of isoleucine and the a/b loci of thymine
and cytosine would sterically clash.
Negative discrimination provides a rationale for D13 (in HD
and ND RVDs) exclusively targeting cytosine; the carboxylate
moiety on D13 forms a stabilizing interaction with the amino
group on C4 (b) of cytosine, but would clash with the methyl group
on C5 (a) of thymine, and would provide destabilizing interactions
with the lone pair of the pyridine-like nitrogen N7 (c) of either
purines. Another illustration of negative discrimination is thymine
targeted by NG, HG or N* RVDs. Here, any side-chain would
clash with the methyl group at the a locus and thus only absence of
side-chain (i.e. G or *) can avoid this unfavourable interaction.
Finally, even though scarcely present in the crystal structures, the
specificity of the NS RVD can also be rationalized with the aid of
the pharmacophore-like model and shown to be consistent with
experimental findings. Indeed, as for the other amino acids present
at position X13, the side-chain of serine is too small to allow a
complete sampling of all loci and is therefore only able to properly
discriminate thymine on a steric basis, thus agreeing with early
observations about serine specificity [4]. More recently [22], NS
has been shown to possess a stronger preference for purines over
cytosine. Negative discrimination again explains this observation
since their respective electrostatic distributions make the side-chain
of serine interact better with either purine than with cytosine
(Figure 4B).
Based on the interpretation provided by the pharmacophore-
like model, the large dominance of non-specific energetic
contributions to TAL-DNA binding and the low fluctuation of
the RVD loop – resulting in incomplete molecular recognition –
we suggest that sequence specificity is not achieved through
positive recognition of nucleobases but instead stems from negative
discrimination, i.e. the match between base and RVD corresponds
to the least bad option available when taking steric and
electrostatic contributions into account. Furthermore, the little
space available at the TAL-DNA interface only allows for small
amino acids to be present, thus providing an explanation for the
subset composition of the naturally-occurring RVDs. Energy
calculations showed that RVD-DNA interactions account for only
a small portion of the total binding energy (Figure 3B/C),
nonetheless, the fact that multiple repeats (at least 10.5) are needed
to produce full activity [5] suggests that the free energy
contributions (i.e. enthalpy and entropy) of each repeat to TAL
binding are likely on a similar scale; any small RVD mismatch
would have an energetic cost that would turn protein-DNA
binding into an unfavourable process (Figure S12).
The pharmacophore-like model can also be used to predict
DNA-recognition by uncommon RVDs that are not present in the
crystal structures available. Targeting guanosine is a concern in
biotechnological applications since NN is the only common RVD
recognizing this base but displays selectivity for both purines. This
prompted the search for an alternative. Cong et al. recently
reported the rare NH RVD as displaying high specificity for
guanine while retaining biological activity when incorporated into
TAL constructs [47]. Application of the pharmacophore-like
model explains this selectivity; the bulky imidazole ring of histidine
would clash with both cytosine and thymine (loci a, b) making
purine bases a less bad option. The high discrimination between
adenine and guanine could be attributed to the pKa of histidine,
Figure 4. Schematic representation of the TAL-DNA interface. (A) Cartoon representation of one single repeat interacting with DNA. The
oxyanion clip (G14, K16 and Q17) interacts with the phosphate group of the (i-1)th base, thus fixing the position of the X13 side-chain with respect to
the ith base and freezing its structural fluctuation. Dashed circles indicate the interaction radii of different X13 residues, sorted by side-chain size: the
inner circle corresponds to G13/*13, while the others are represented by the outer circle. Only loci a, b and c are sampled by the side-chains of X13,
resulting in incomplete molecular differentiation. (B) Pharmacophore-like model for the nucleobases discussed in the text (left). Dots represent sites
with variable properties across nucleobases; colours are used to highlight the characteristics of the substituents: green for pyridine-like (H-bond
acceptor) nitrogen atoms, blue for pyrrole-like and amine (H-bond donor) nitrogen atoms, grey for methyl groups, and red for carbonyl oxygen
atoms. On the right, relative molecular electrostatic potential (MEP) maps for the corresponding nucleobases are reported. Calculations were
performed at the QM level on methyl-capped purines (N9) and pyrimidines (N1) (red = 25.0 kBT/e, blue = 5.0 kBT/e, isovalue 4.0 E
24).
doi:10.1371/journal.pone.0080261.g004
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making the charged histidine a much better match to the
electrostatic potential displayed by guanine as compared with
that of adenine (Figure 4B). Those findings were further supported
by Streubel et al., who demonstrated that NH was selective for
guanine although reducing activity of TAL constructs [22]. The
size of the imidazole ring and the resulting steric crowding is likely
to be the source of the reduced efficiency associated with this
RVD.
Lysine (in NK RVD) has even greater specificity for guanine
[6,7,22,48]; the positively charged amino moiety at the tip of the
long side-chain interacts better with guanine than with adenine or
cytosine, due to differences in charge distribution (cf. electron
densities at loci b, c and e in Figure 4B). On the other side, the
methyl group on cytosine C5 would generate destabilizing steric
clashes with the long lysine side-chain, providing another example
of negative discrimination.
TAL design and DNA methylation
Although NK binds guanine more specifically than NN does, it
leads to less efficient TAL constructs [22,49]. The lysine side-
chain, due to its size, probably does not perfectly fit in the narrow
gap between the RVD loop and DNA, thus impairing binding. We
used geometry optimization of single and double TAL mutants to
generate new RVD loops in silico, which we hope will retain the
stronger selectivity of K13 for guanine without overall loss in
binding efficiency (cf. Figure 5 and Methods S1). We supposed that
deletions in the RVD loop could provide the extra space needed to
properly accommodate the large side-chain of lysine and not
interfere with the DNA-binding. On the basis of our calculations,
we propose that the mutants *13-G14K (deletion of X13 and
mutation G14K) and K13-*14 (deletion of G14) could be used as
effective guanine-targeting RVDs, replacing both NK and NN.
Finally, extension of the pharmacophore-like model to methyl-
ated DNA bases helps understanding the shared affinity of the N*
RVD for thymine and cytosine as well as providing insight into
DNA methylation with respect to TAL binding [4,5] (Methods
S1). DNA methylation, in particular the formation of 5-
methylcytosine (mC) is frequent in plants [50] and is also an
important epigenetic regulatory mechanism. Modelling of 5-
methylcytosine revealed that locus a features the same steric
hindrance and electrostatic distribution as thymine (Figure 4B),
thus altering the major-groove facet of cytosine upon methylation.
N* lacking a side-chain – preventing discrimination further than
the a locus – fails to discriminate between 5-methylcytosine and
thymine (and cytosine, which lacks the a locus). Consistent with
our model, binding energies are indeed not affected significantly
when substituting cytosine for 5-methylcytosine or thymine (Table
2). Those data are in agreement with the similar affinities of N* for
cytosine and thymine reported by Moscou et al. [4]. It is tempting
to speculate that N* might have evolved as a versatile RVD
capable of leaving TAL DNA-binding unaffected in case of
cytosine C5-methylation. The recent study of Deng et al. [23] on 5-
methyltcytosine DNA targeted by NG revealed no differences in
binding when compared to thymine equivalents. Their crystal
structure showed a van der Waals contact between methylated
DNA bases and NG that resembles thymine targeting by the same
RVD. The lack of side-chain in glycine makes it almost identical to
N*; on the basis of the pharmacophore-like model, NG and N* are
equivalently treated with respect to nucleobase sampling (Figure
4A). Thus, we suppose that under similar experimental conditions
N* would show comparable results as NG.
Conclusions
The dynamical study described in this report suggests that the
composition of each RVD can be deconvoluted into its constituent
parts and their contributions treated separately. X12 only interacts
with the protein at the helix-RVD-loop transition. Together with
the low a-helix propensities of both H and N, it suggests a purely
structural role for X12, associated with the disruption of the a1
helix in order to allow proper folding of the RVD-loop and dense
wrapping of DNA. By extension, X13 seems to be the sole player
in DNA sequence recognition. However, the energetic pattern of
TAL-DNA binding shows a strong dominance of the oxyanion clip
(GGKQ) and a small contribution from X13. This suggests a
mechanism of negative discrimination between X13 and the
nucleobase. The low structural fluctuation of the RVD-loop
imposed by the oxyanion clip in the bound state allowed us to devise
a pharmacophore-like model for rationalization of the RVD-to-
DNA code. The structurally-imposed incomplete molecular
recognition of nucleobases by X13 explains the selectivity of the
different RVDs and their shared affinities. The observation of a
significant interaction between X13 and the preceding DNA base
might provide an explication for the context-dependence of TAL
activities. We hope that the recognition mechanism proposed
herein will allow for more efficient rational designs, deepening
alongside our knowledge of the intricate, yet very elegant
architecture of TAL proteins.
Figure 5. Protein-DNA interactions of potentially improved
RVD loops for targeting guanine. (A) Wild type (N12-N13) alone
(grey) and superposed to: (B) N12-N13K mutant (yellow), (C) N13K-G14*
mutant (green) and (D) N13*-G14K mutant (magenta).
doi:10.1371/journal.pone.0080261.g005
Table 2. Protein-DNA binding energies for modified targets
of repeat 7 (N*) of the PthXo1 system (TAL[22.5]/P1).
MM/GBSA [kcal/mol] MM/PBSA [kcal/mol]
Cytosine (wild type) 2147.36 (+/2 15.96) 25.87 (+/2 27.74)
Thymine (with
Adenine)
2148.22 (+/2 15.95) 27.37 (+/2 27.48)
52methylcytosine 2149.77 (+/2 15.90) 28.21 (+/2 27.35)
The base pairs corresponding to each category are: wild type (CG), mutated (TA)
and 5-methylcytosine (mCG). See Methods S1 for details.
doi:10.1371/journal.pone.0080261.t002
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Supporting Information
Figure S1 Root Mean Square Deviations (RMSD).
Calculations performed on Ca and P atoms for different portions
of the systems (labels in the upper-right box of each graph). The
overall RMSD for each portion as well as the corresponding
standard deviation (in brackets) are reported next to each label. (a)
TAL[22.5]/P1, (b) TAL[22.5]/P2, (c) TAL[11.5]/P1, (d)
TAL[11.5]/P1-apo, (e) TAL[11.5]/P3, (f) TAL[11.5]/P4 and
(g) TAL[10]/P1-apo. Analyses done with ProDy and plotted with
Matplotlib Python libraries.
(TIF)
Figure S2 Projection of the first four normal modes
onto the trajectory. Normal modes obtained by Essential
Dynamics Analysis (protein Ca atoms) of the MD trajectories.
Labels are reported in the upper-right box of each graph, together
with the statistical weight of each normal mode (in brackets). (a)
TAL[22.5]/P1, (b) TAL[22.5]/P2, (c) TAL[11.5]/P1, (d)
TAL[11.5]/P1-apo, (e) TAL[11.5]/P3, (f) TAL[11.5]/P4 and
(g)TAL[10]/P1-apo. Analyses were done with ProDy and plotting
with Matplotlib Python libraries.
(TIF)
Figure S3 Root Mean Square Fluctuation (RMSF).
Calculations performed on protein Ca atoms. (a) TAL[22.5]/P1,
(b) TAL[22.5]/P2, (c) TAL[11.5]/P1, (d) TAL[11.5]/P1-apo, (e)
TAL[11.5]/P3, (f) TAL[11.5]/P4 and (g)TAL[10]/P1-apo. Anal-
yses done with ProDy and plotting with Matplotlib Python
libraries.
(TIF)
Figure S4 Secondary structure time evolution. The
colours represent the different secondary structure elements (blue:
a-helix; white: coil/turn; orange: b-sheet). (a) TAL[22.5]/P1, (b)
TAL[22.5]/P2, (c) TAL[11.5]/P1, (d) TAL[11.5]/P1-apo, (e)
TAL[11.5]/P3, (f) TAL[11.5]/P4 and (g)TAL[10]/P1-apo. Anal-
yses done with VMD and plotting with Matplotlib Python
libraries.
(TIF)
Figure S5 Average Root Mean Square Fluctuation
(RMSF) per TAL repeat. Calculations performed on protein
Ca atoms. (a) TAL[22.5]/P1, (b) TAL[22.5]/P2, (c) TAL[11.5]/
P1, (d) TAL[11.5]/P1-apo, (e) TAL[11.5]/P3, (f) TAL[11.5]/P4
and (g)TAL[10]/P1-apo. Repeats containing a deletion were
excluded from the statistics. Standard deviation values are
reported as error bars. Analyses done with ProDy and plotting
with Matplotlib Python libraries.
(TIF)
Figure S6 Per-residue decomposition of the intra-pro-
tein total interaction energy. Calculations performed on the
TAL[22.5]/P1 system using the MM/GBSA (single-trajectory)
approach. Graph obtained by taking the average per repeat and
displaying a three-repeat window. For clarity, only values below
20.5 kcal/mol are reported.
(TIF)
Figure S7 Per-residue decomposition of the intra-pro-
tein interaction energy (only backbone contributions).
Calculations performed on the TAL[22.5]/P1 system using the
MM/GBSA (single-trajectory) approach. Graph obtained by
taking the average per repeat and displaying a three-repeat
window. For clarity, only values below 20.5 kcal/mol are
reported.
(TIF)
Figure S8 Per-residue decomposition of the intra-pro-
tein interaction energy (only side-chain contributions).
Calculations performed on the TAL[22.5]/P1 system using the
MM/GBSA (single-trajectory) approach. Graph obtained by
taking the average per repeat and displaying a three-repeat
window. For clarity, only values below 20.5 kcal/mol are
reported.
(TIF)
Figure S9 Decomposition of the protein-DNA total
interaction energy of TAL[22.5]/P1. Calculations performed
on the model system TAL[22.5]/P1 using the MM/GBSA (single-
trajectory) approach. For clarity, only values below20.5 kcal/mol
are reported.
(TIF)
Figure S10 Decomposition of the protein-DNA total
interaction energy of TAL[11.5]/P1. Calculations performed
on the model system TAL[11.5]/P1 using the MM/GBSA (single-
trajectory) approach. For clarity, only values below20.5 kcal/mol
are reported.
(TIF)
Figure S11 Contributions from different sections of
TAL to the total protein-DNA binding energy (subdivid-
ed by type). Calculation performed using the MM/GBSA
(single-trajectory) approach. (a) TAL[22.5]/P1, (b) TAL[22.5]/
P2, (c) TAL[11.5]/P3, (d) TAL[11.5]/P4 and (e) TAL[11.5]/P1.
Colour-code of the repeat-specific bars; red=G13, yellow=N13,
blue =D13 and green= I13 (a and b) or green = S13 (c, d and e).
(TIF)
Figure S12 Contributions from an increasing number of
TAL repeats to the total protein-DNA binding energy.
Calculations performed using the MM/GBSA and MM/PBSA
(single-trajectory) approaches on model system TAL[22.5]/P1 (cf.
Methods S1 for details).
(TIF)
Methods S1 Supporting methods and references.
(PDF)
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